Anthem Biosciences: Ravindra Chandrappa Re-appointed as Director

Anthem Biosciences Ltd's Board of Directors approved several key items at its meeting on May 19, 2026. These include audited financial results for the year ended March 31, 2026, a final dividend of ₹2.00 per share, convening the 20th Annual General Meeting on July 22, 2026, and the allotment of 14,81,250 equity shares under the ESOP 2024. The board also approved the re-appointment of M/s. BPU & Co. as Internal Auditor and recommended the continuation of Mr. Ravikant Uppal and the re-appointment of Mr. Ravindra Chandrappa as Directors, subject to shareholder approval.